Related Experiment Videos
[Recombinant antibodies in serologic diagnosis]
A Wölpl1, M Cardoso, K Siemoneit
1DRK-Blutspendezentrale Ulm, Abteilung Transfusionsmedizin, Universität Ulm, BRD.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1993
Summary
This study introduces a novel recombinant antibody production method, ideal for unstable human antibody cell lines. A new human antibody targeting the hepatitis C virus (HCV) core protein is presented as an example.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Context:
- Instability of human antibody-producing cell lines poses challenges for monoclonal antibody production.
- Recombinant DNA technology offers a potential solution to overcome these limitations.
Purpose:
- To present a novel methodology for producing monoclonal antibodies using recombinant techniques.
- To demonstrate the utility of this approach for generating human monoclonal antibodies.
- To showcase a specific application: a recombinant human antibody against the hepatitis C virus (HCV) core protein.
Summary:
- A new recombinant methodology for monoclonal antibody production is discussed.
- This technique is particularly advantageous for human monoclonal antibodies due to the inherent instability of human antibody-producing cell lines.
- The paper details the successful generation of a recombinant human antibody targeting the hepatitis C virus (HCV) core protein.
Impact:
- Provides a robust alternative for producing therapeutic human monoclonal antibodies.
- Facilitates the development of novel diagnostics and therapeutics for diseases like hepatitis C.
- Advances the field of antibody engineering and biopharmaceutical production.